Glyphosate found in more than 80% of U.S. urine samples
Glyphosate was listed as a probable human carcinogen by the World Health Organization’s International Agency for Research on Cancer in 2015.
“Hope is not a strategy”: Emergency doctor asks, where are COVID-19 tests? Where is...
“First we’re going to run out of masks, and then we’re going to run out of doctors and nurses, because they’ll become sick.”
As COVID-19 cases spike, epidemiologist warns ‘the road to an uncertain vaccine is paved...
We speak with Dr. Ali Khan, epidemiologist and the dean of the College of Public Health at the University of Nebraska Medical Center, about the Trump administration’s handling of the crisis and his hopes for a vaccine.
How Monsanto plants stories, suppresses science & silences dissent to sell a cancer-linked chemical
The company attempted to censor and discredit anyone and anything that contradicted their business interests.
Will the Trump USDA deliver on the dietary guidelines for Americans? Our new report...
The bottom line is this: if it is important to ensure the guidelines are evidence-based, it is essential to recognize that even evidence-based guidelines are only as effective as their implementation.
Stay home, stay safe, be kind: What New Zealand can teach the world about...
Some of the country’s success has been attributed to her leadership, trust in science, and clear communication during the crisis.
America’s dairyland may have a PFAS problem
First, there was Fred Stone, the third-generation dairy farmer in Maine who discovered that the milk from his cows contained harmful chemicals. Then...
The food industry puts profits over public health using big tobacco’s playbook
In certain cases, preemption—when a higher level of government limits the authority of a lower level to enact new policies—can devastate public health.
2.2 million petition demanding Medicare for All
Yesterday, 2.2 million petition signatures were delivered to the U.S. House of Representatives to show support of Medicare for All.
Gilead Sciences asks FDA to rescind ‘orphan’ status for possible coronavirus treatment drug in...
"We are committed to making the medicine both accessible and affordable to governments and patients around the world."